BrightFocus funds U.S. and international research aimed at enhancing understanding, prevention, and treatment of glaucoma and other diseases, having contributed over $35 million towards glaucoma research since 1978.
The National Glaucoma Research Program is designed to support pioneering research into the greater understanding, prevention, and treatment of glaucoma. It has a history of funding significant research efforts including innovative mechanisms for eye fluid drainage, protective measures for nerve cells in the eyes, and advancements in cell replacement therapies and gene delivery methods for glaucoma. The standard award targets researchers requiring further progress to secure additional funding, offering $200,000 over two years.